Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Wen-Jiun Chou,1 Liang-Jen Wang,1 Chien-Ho Lin,2 Sun-Yuan Liang,3 Vincent Chin-Hung Chen,4 Yuh-Ming Hou,5 Rong-Rong Huang,6 Miao-Chun Chou,1 Chi-Yung Shang,7 Chi-Pui Ho,6 Meng-Chuan Lai8 1Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University...

Full description

Bibliographic Details
Main Authors:	Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	ADHD central nervous system stimulant drug adherence family social adjustment
Online Access:	https://www.dovepress.com/social-adjustment-and-family-function-after-drug-switch-from-ir--methy-peer-reviewed-article-NDT

Similar Items

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial
by: Kooij J J Sandra, et al.
Published: (2013-01-01)

Editorial: Attention and Methylphenidate
by: Avi Avital, et al.
Published: (2020-04-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
by: Johanne Pereira Ribeiro, et al.
Published: (2021-08-01)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
by: Lee H, et al.
Published: (2020-05-01)

Methylphenidate-Induced Raynaud’s Phenomenon In Two Cases With Attention-Deficit/Hyperactivity Disorder
by: Hurşit Ferahkaya, et al.
Published: (2021-05-01)

The effect of Methylphenidate-OROS® on the narrative ability of children with ADHD
by: Rausch, Tessa L.
Published: (2015)

A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Effect of one-month treatment with methylphenidate on salivary cortisol level of attention deficit hyperactivity disorder children
by: Esraa Yahia Kholif, et al.
Published: (2021-03-01)

ADHD, Methylphenidate, and Childhood Epilepsy
by: Rahul Sharma, et al.
Published: (2016-08-01)

Methylphenidate in ADDH and Epilepsy
by: J Gordon Millichap
Published: (1994-10-01)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
by: Chan MH, et al.
Published: (2017-04-01)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
by: Sunsha Chamakalayil, et al.
Published: (2021-01-01)

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
by: Huang Yu-Shu, et al.
Published: (2012-11-01)

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
by: Philip Asherson, et al.
Published: (2019-12-01)

A comparison of effectiveness of regulation of working memory function and methylphenidate on remediation of attention deficit hyperactivity disorder (ADHD).
by: Mohammad Reza Mohammadi, et al.
Published: (2014-03-01)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
by: Huss M, et al.
Published: (2016-05-01)

Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study
by: Ahmet Çevikaslan, et al.
Published: (2021-01-01)

The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
by: A Schrantee, et al.
Published: (2017-01-01)

Alopecia associated with use of methylphenidate: A case series
by: Sundar Gnanavel, et al.
Published: (2018-01-01)

A Comparison of Effectiveness of Parent Behavioral Management Training and Methylphenidate on Reduction of Symptomsof Attention Deficit Hyperactivity Disorder
by: Mohammad Reza Mohammadi, et al.
Published: (2016-09-01)

Memantine versus Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial
by: MohammadReza Mohammadi, et al.
Published: (2016-02-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
by: Jain Rakesh, et al.
Published: (2011-11-01)

The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
by: Tessa L. Rausch, et al.
Published: (2017-02-01)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
by: Parvin Safavi, et al.
Published: (2016-01-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials
by: A. R. Müller, et al.
Published: (2021-09-01)

OROS Methylphenidate in Adolescents with ADHD
by: J Gordon Millichap
Published: (2006-01-01)

Methylphenidate use in children with attention deficit hyperactivity disorder
by: Felipe Salles Neves Machado, et al.
Published: (2015-01-01)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
by: Jan K Buitelaar, et al.
Published: (2009-08-01)

Methylphenidate in Hyperactive Autistic Children
by: J Gordon Millichap
Published: (1988-04-01)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
by: Alekhya Mandali, et al.
Published: (2021-01-01)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
by: Hoda Shirafkan, et al.
Published: (2020-03-01)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
by: Sharon Shem-Tov BSc, et al.
Published: (2019-05-01)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
by: Maria Bernarda Pitzianti, et al.
Published: (2020-09-01)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
by: Onur İsmi, et al.
Published: (2018-07-01)

Predictors of Treatment Response to Methylphenidate in Attention-deficit/hyperactivity Disorder
Published: (2016)

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?
by: Wang LJ, et al.
Published: (2017-05-01)

Methylphenidate does not affect convergent and divergent creative processes in healthy adults
by: Matthijs Baas, et al.
Published: (2020-01-01)